HALOZYME THERAPEUTICS INC 4
4 · HALOZYME THERAPEUTICS INC · Filed May 5, 2017
Insider Transaction Report
Form 4
BIZZARI JEAN-PIERRE
Director
Transactions
- Award
Common Stock
2017-05-04+14,135→ 50,949 total
Footnotes (1)
- [F1]Represents annual restricted stock grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 4, 2018 and (ii) the date of the Issuer's next annual meeting of stockholders.